The countdown begins to the highly anticipated Adaptive Designs in Clinical Trials conference in April this year. With the growing popularity in use and acceptance of adaptive designs in clinical ...

From 2006-2008, he was Chief Medical Officer and Vice President of Clinical Affairs at Napo Pharmaceuticals, where he co-authored the two-stage pivotal adaptive trial design leading to approval of ...

PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials ...

As oncology research centers scale eSource adoption, the field is shifting toward a fully digital, clinical trial ecosystem.

Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...

The MIRACLE study is a Phase 2B/3 clinical trial whereby data from the 2B ... the FDA and their foreign equivalents, utilizes an adaptive design whereby the first 75 to 90 subjects will be ...

Technological advancements such as artificial intelligence (AI), big data analytics, and decentralized trials are ...

The Clinical Trial Success Prediction capability ... and CROs are leveraging PhaseV's platform to rapidly design and execute adaptive, Bayesian and fixed clinical trials, analyze data to uncover ...

Chong added that, generally, the clinical trial landscape has ... From a trial design perspective, this coincides with the emergence of adaptive, challenge and platform trials that have ...